BofA analyst Sherif El-Sabbahy raised the firm’s price target on Legence (LGN) to $62 from $55 and keeps a Buy rating on the shares after the company reported what the firm calls “a second set of solid results as a public firm.” The firm raised its topline estimates 9% on the updated outlook, while its EBITDA estimates increase 10%-14%, the analyst noted.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
